Tomoaki Yoshimura 吉村知哲

Researcher Number	70985085
Other IDs
Affiliation (Current)	2025: 岐阜薬科大学, 薬学部, 教授
Affiliation (based on the past Project Information) *help	2023 – 2024: 岐阜薬科大学, 薬学部, 教授
Review Section/Research Field	Except Principal Investigator Basic Section 90140:Medical technology assessment-related / Basic Section 47060:Clinical pharmacy-related
Keywords	Except Principal Investigator データマイニング / 計算科学 / リアルワールドデータ / シグナル / 2群間比較 / 医薬品相互作用 / 支持療法 / 薬剤適正使用 / 副作用対策 / がん薬物療法 / 高齢者

Establishment of optimal cancer chemotherapy for elderly cancer patients based on a multicenter study
- Principal Investigator
  
  小林亮
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Gifu Pharmaceutical University
ビッグデータを活用したエビデンスの高い医薬品相互作用の安全性シグナル探索法の構築
- Principal Investigator
  
  野口義紘
- Project Period (FY)
  2022 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 90140:Medical technology assessment-related
- Research Institution
  Gifu Pharmaceutical University

All 2024 2023

All Journal Article Presentation

[Journal Article] Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug?drug interactions2023
- Author(s)
  Noguchi Yoshihiro、Yoshimura Tomoaki
- Journal Title
  
  Pharmacoepidemiology and Drug Safety
  
  Volume: 33 Issue: 1
- DOI
  10.1002/pds.5722
- Data Source
  KAKENHI-PROJECT-22K12890
[Journal Article] Comment on: "Drug-associated kidney injury in children: a disproportionality analysis of the FDA adverse event reporting system"2023
- Author(s)
  Noguchi Yoshihiro、Yoshimura Tomoaki
- Journal Title
  
  European Journal of Pediatrics
  
  Volume: 183 Issue: 2 Pages: 975-976
- DOI
  10.1007/s00431-023-05265-w
- Data Source
  KAKENHI-PROJECT-22K12890
[Journal Article] Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System2023
- Author(s)
  Noguchi Yoshihiro、Yoshimura Tomoaki
- Journal Title
  
  The Journal of Clinical Pharmacology
  
  Volume: 63 Issue: 10 Pages: 1169-1170
- DOI
  10.1002/jcph.2324
- Open Access
- Data Source
  KAKENHI-PROJECT-22K12890
[Journal Article] Is it possible to identify risk factors for adverse drug reactions using a pharmacovigilance database based on spontaneous reporting?2023
- Author(s)
  Noguchi Yoshihiro、Yoshimura Tomoaki
- Journal Title
  
  Pharmacoepidemiology and Drug Safety
  
  Volume: 33 Issue: 1
- DOI
  10.1002/pds.5737
- Data Source
  KAKENHI-PROJECT-22K12890
[Journal Article] Comment on: Drugs That Interact With Colchicine via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)2023
- Author(s)
  Noguchi Yoshihiro、Yan Miao、Yoshimura Tomoaki
- Journal Title
  
  Annals of Pharmacotherapy
  
  Volume: 58 Issue: 2 Pages: 196-197
- DOI
  10.1177/10600280231168858
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K12890
[Journal Article] Questioning Bayesian Inference‐Based Models for Estimating Culprit Drugs for Adverse Drug Reactions2023
- Author(s)
  Noguchi Yoshihiro、Yan Miao、Yoshimura Tomoaki
- Journal Title
  
  Clinical Pharmacology & Therapeutics
  
  Volume: 114 Issue: 2 Pages: 259-259
- DOI
  10.1002/cpt.2933
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K12890
[Journal Article] Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database2023
- Author(s)
  Asano Hiroki、Noguchi Yoshihiro、Kimura Michio、Usami Eiseki、Yoshimura Tomoaki
- Journal Title
  
  Medicina
  
  Volume: 59 Issue: 11 Pages: 1963-1963
- DOI
  10.3390/medicina59111963
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] メトホルミンとイメグリミンの安全性プロファイルの違い2024
- Author(s)
  髙橋優太，増田陸人，宍戸正昂，野口義紘，吉村知哲
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] リアルワールドデータを用いたアビラテロンを対照としたエンザルタミドの心血管有害事象のリスク評価2024
- Author(s)
  増田陸人，相沢晴霞，吉澤俊輔，野口義紘，野村由貴，佐口弥，井口和弘，吉村知哲
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] 米国FDAの副作用自発報告データベース用いたアビラテロンおよびエンザルタミドの有害事象の網羅的探索2024
- Author(s)
  相沢晴霞，増田陸人，野口義紘，宍戸正昂，勅使河原裕大，吉村知哲
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] 特定患者群の医薬品相互作用に関するシグナル検出手法の提案2024
- Author(s)
  野口義紘，森卓之，宇佐美英績，吉村知哲
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] Dipeptidyl Peptidase-4阻害薬による類天疱瘡の発現と性差2024
- Author(s)
  野口義紘，宍戸正昂，岸杏澄，吉村知哲
- Organizer
  第17回日本性差医学・医療学会学術集会
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] SGLT 2阻害薬に起因する高齢者特有の有害事象の探索2024
- Author(s)
  岸杏澄，宍戸正昂，野口義紘，吉村知哲
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] 日本の自発報告データベース（JADER）を用いた DPP-4阻害薬の有害事象発現における男女差の解析2023
- Author(s)
  宍戸正昂，野口義紘，舘知也，吉村知哲
- Organizer
  第33回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-22K12890
[Presentation] 自発報告データベースを用いた抗アンドロゲン薬の有害事象の網羅的解析2023
- Author(s)
  奥村茉衣子，野口義紘，野村由貴，井口和弘，佐口弥，吉村知哲
- Organizer
  日本社会薬学会第41年会
- Data Source
  KAKENHI-PROJECT-22K12890

1. 小林亮 (50555662)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 鈴木昭夫 (80775148)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 伊野陽子 (90973355)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 野口義紘 (80724608)

# of Collaborated Projects: 1 results

# of Collaborated Products: 15 results
5. 舘知也 (80618447)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 寺町ひとみ (20405129)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Tomoaki Yoshimura 吉村 知哲

Research Projects

Research Products

Co-Researchers

Establishment of optimal cancer chemotherapy for elderly cancer patients based on a multicenter study

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

ビッグデータを活用したエビデンスの高い医薬品相互作用の安全性シグナル探索法の構築

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug?drug interactions2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comment on: "Drug-associated kidney injury in children: a disproportionality analysis of the FDA adverse event reporting system"2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Is it possible to identify risk factors for adverse drug reactions using a pharmacovigilance database based on spontaneous reporting?2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comment on: Drugs That Interact With Colchicine via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Questioning Bayesian Inference‐Based Models for Estimating Culprit Drugs for Adverse Drug Reactions2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database2023

Author(s)

Journal Title

DOI

Data Source

[Presentation] メトホルミンとイメグリミンの安全性プロファイルの違い2024

Author(s)

Organizer

Data Source

[Presentation] リアルワールドデータを用いたアビラテロンを対照としたエンザルタミドの心血管有害事象のリスク評価2024

Author(s)

Organizer

Data Source

[Presentation] 米国FDAの副作用自発報告データベース用いたアビラテロンおよびエンザルタミドの有害事象の網羅的探索2024

Author(s)

Organizer

Data Source

[Presentation] 特定患者群の医薬品相互作用に関するシグナル検出手法の提案2024

Author(s)

Organizer

Data Source

[Presentation] Dipeptidyl Peptidase-4阻害薬による類天疱瘡の発現と性差2024

Author(s)

Organizer

Data Source

[Presentation] SGLT 2阻害薬に起因する高齢者特有の有害事象の探索2024

Author(s)

Organizer

Data Source

[Presentation] 日本の自発報告データベース（JADER）を用いた DPP-4阻害薬の有害事象発現における男女差の解析2023

Author(s)

Organizer

Data Source

[Presentation] 自発報告データベースを用いた抗アンドロゲン薬の有害事象の網羅的解析2023

Tomoaki Yoshimura 吉村知哲